Article

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

2022-06-06

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The activities of MYC, the androgen receptor, and its associated pioneer factors demonstrate substantial reprogramming between early and advanced prostate cancer. Although previous studies have shown a shift in cellular metabolic requirements associated with prostate cancer progression, the epigenetic regulation of these processes is incompletely described. Here, we have integ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bfab70d3-3dd9-5786-a0a4-3ca54fcf1719
DOI: 10.1101/2022.06.04.22276001

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2ADOI 10.1101/2022.06.04.22276001Read

Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancerSemantic proximity Read

Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression.Semantic proximity Read

Integrated multi-omics profiling uncovers the epigenetic, transcriptional, and metabolic landscape of prostate cancer progressionSemantic proximity Read

Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancerSemantic proximity Read

MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancerSemantic proximity Read

Single-cell analysis reveals a kynurenine pathway enriched epithelial subpopulation and a HAAO/QA-FDPS metabolic axis in prostate cancerSemantic proximity Read

Inhibition of KDM4C/c‐Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolismSemantic proximity Read

KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis.Semantic proximity Read

Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic ImplicationsSemantic proximity Read

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Semantic proximity Read

MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activitySemantic proximity Read

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC programSemantic proximity Read